Use of PCR-RFLP and PCR-HWP۱ for identification of Candida species isolated from cystic fibrosis patients

سال انتشار: 1393
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 51

فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_REMJ-2-3_004

تاریخ نمایه سازی: 22 دی 1402

چکیده مقاله:

Background: Due to the predisposing conditions in patients with cystic fibrosis (CF) caused by defective mucociliary clearance facilitating colonization and invasion with Candida species has dramatically increased. Traditional methods for identifying problems are imminent and time-consuming. Therefore, molecular techniques utilizing amplification of target DNA provide quick and precise methods for the diagnosis and identification of Candida species. Therefore, the aim of the current study was to identify the most medically common isolated Candida species from the air way of CF patients by PCR-RFLP and amplification of HWP۱ gene. Materials and Methods: A total of ۴۲ CF patients presenting symptoms who referred to pediatric respiratory diseases research center were screened for the presence of Candida spp. The isolates initially were phenotypically identified and confirmed by molecular approaches based on restriction fragment length polymorphism ( PCR -RFLP) for the discrimination of C. albicans of non-albicans and the amplification of HWP۱ gene for the discrimination of C. albicans from C. dubliniensis and C. africana was conducted. Results: The results show that C. albicans was the most frequently isolated species (۸۳.۸%) followed by non-albicans included C. parapsilosis (۷.۱%), C. glabrata (۳.۲%), and C. tropicalis (۳.۲%). The restriction patterns of each Candida species were perfectly specific. Since MspI could not discriminate between the three morphological related species, C. albicans, C. dubliniensis and C. africana, we used PCR amplification of HWP۱ gene, which (۷.۱%) species from C. albicans identified as C. dubliniensis, however C. africana strains were not found. Conclusion: The present study found that C. albicans as predominant species wereisolated from the CF patients. It could be concluded that molecular diagnostic methods are reliable and would be useful for the identification of medically important Candida species in clinical samples . Therefore, considerable attention has been paid to the prevention and treatment of microbial growth, which has resulted in the improvement of patient management.

نویسندگان

Peyman Solimani

۱Department of Medical Mycology and Parasitology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

Samira Salari

۱Department of Medical Mycology and Parasitology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

Soheila khalizadeh

۲Pediatric Respiratory Diseases Research Center, NRITLD, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Maryam Hassanzad

۲Pediatric Respiratory Diseases Research Center, NRITLD, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Sadegh Khodavaisy

۳Department of Medical Mycology and Parasitology, Kurdistan University of Medical Sciences, Sanandaj, Iran

Mahdi Abastabar

۵Invasive Fungi Research Centre (IFRC)/Department of Medical Mycology and Parasitology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran

Hamed Fakhim hajiaghaei

Student Research Committee, Mazandaran University o f Medical Sciences, Sari, Iran

Hamid Badali

۵Invasive Fungi Research Centre (IFRC)/Department of Medical Mycology and Parasitology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Davis PB, Drumm M, Konstan MW: Cystic fibrosis. Am JRespir ...
  • ۱۹۹۶; ۱۵۴: ۱۲۲۹ ...
  • PMID: ۸۹۱۲۷۳۱۲. LambiaseA, RaiaV, PezzoM, SepeA, CarnovaleV,RossanoF. Microbiology of airway ...
  • ۲۰۰۶; ۶:۱ ...
  • PMID: ۱۶۴۰۵۷۲۱۳. Lyczak JB, Cannon CL,Pier GB. Lung infections associatedwith ...
  • ۲۰۰۲; ۱۵: ۱۹۴–۲۲۲ ...
  • PMID: ۱۱۹۳۲۲۳۰۴. Muller FC, Seidler M. Characteristics of pathogenic fungi ...
  • ۲۰۱۰; ۸: ۹۵۷–۹۶۴. PMID: ۲۰۶۹۵۷۵۰۵ ...
  • Salunkhe P, Smart CH, Morgan JA., Panagea S, Walshaw MJ,Hart ...
  • Cystic fibrosisepidemic strain ofPseudomonas aeruginosadisplays enhancedvirulence and antimicrobial resistance. J ...
  • ۲۰۰۵; ۱۸۷:۴۹۰۸–۴۹۲۰. PMID: ۱۵۹۹۵۲۰۶۶. Alvarez AE, Ribeiro AF, Hessel G, ...
  • Cystic fibrosis at a Brazilian center of excellence: clinical andlaboratory ...
  • term fungal cultures from sputum of patients with cysticfibrosis. Mycoses ...
  • ۱۹۹۱; ۳۴: ۳۷۳–۳۷۶. PMID: ۱۸۲۰۵۱۵۸. Chotirmall SH, Greene CM, McElvaney ...
  • Candidaspecies incystic fibrosis: a road less travelled. Med Mycol ...
  • ۲۰۱۰; ۴۸: ۱۱۴ ...
  • PMID: ۲۱۰۶۷۳۲۳۹. Bakare N, Rickerts V, Bargon J, Just ...
  • Nubling G. Prevalence ofAspergillus fumigatusand other fungal species in the ...
  • ۲۰۰۳; ۴۶(۱ ...
  • PMID: ۱۲۵۸۸۴۷۸۱۰. Bauernfeind A, Bertele RM, Harms K, Horl G, ...
  • PMID: ۳۱۱۷۷۰۰۱۱. Blaschke ...
  • Hellmessen R, Spitzer H, Paul KD, Hoffmann C ...
  • Mycological surveillance of children with cystic fibrosis ...
  • ۱۹۹۱; ۳۴:۴۳ ...
  • PMID: ۱۸۱۸۲۶۲۱۲. Nagano Y, Millar BC, Johnson E, et al ...
  • Fungal infectionsinpatients with cystic fibrosis. Rev Med Microbiol. ۲۰۰۷; ۱۸(۱): ...
  • Enzyme PCR ...
  • RFLP assay for identification of six medicallyImportantCandidaspecies. Jpn J Med ...
  • ۲۰۰۶; ۴۷: ۲۲۵ ...
  • PMID: ۱۶۹۴۰۹۵۸۱۴. Romeo O, Criseo G. First molecular method for ...
  • ۲۰۰۸; ۶۲: ۲۳۰–۲۳۳ ...
  • PMID: ۱۸۶۴۰۸۰۳۱۵ ...
  • Sudfeld CR, Dasenbrook EC, Merz WG, Carroll KC, BoyleMP ...
  • Prevalence and risk factors for recovery of filamentous fungiin individuals ...
  • ۲۰۱۰;۹: ۱۱۰–۱۱۶ ...
  • PMID: ۲۰۰۴۵۳۸۴۱۶ ...
  • Chotirmall SH, O’Donoghue E, Bennett K, Gunaratnam C,O’NeillSJ, et al. ...
  • treated exacerbations in cystic fibrosis. Chest,۲۰۱۰;۱۳۸: ۱۱۸۶–۱۱۹۵. PMID: ۲۰۴۷۲۸۵۹۱۷ ...
  • Leclair LW, Hogan DA. Mixed bacterial ...
  • fungal infections inthe CF respiratory tract. Med Mycol ...
  • ۲۰۱۰; ۴۸: S۱۲۵–۳۲. PMID:۲۱۰۶۷۳۲۴۱۸ ...
  • Muthig M, Hebestreit A, Ziegler U, Seidler M, Muller FM ...
  • Persistence ofCandidaspecies in the respiratory tract of cysticfibrosis patients. Med ...
  • PMID: ۱۹۱۸۴۷۷۱۱۹ ...
  • Webb AK, Woolnough E ...
  • Candida albicansinfection in adultswith cystic brosis ...
  • J R Soc Med ...
  • ۲۰۰۶; ۹۹: ۱۳–۱۶ ...
  • Gutierrez J, Morales P, Gonzalez MA, Quindos G ...
  • Candidadubliniensis, a new fungal pathogen ...
  • J Basic Microbiol. ۲۰۰۲;۴۲(۳):۲۰۷ ...
  • PMID: ۱۲۱۱۱۷۴۸۲۱ ...
  • Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE,Coleman DC ...
  • Candida dubliniensissp. nov.: phenotypic andmolecular characterization of a novel species ...
  • infected individuals. Microbiology,۱۹۹۵;۱۴۱(Pt ۷):۱۵۰۷ ...
  • PMID: ۷۵۵۱۰۱۹۲۲. Polacheck I, Strahilevitz J, Sullivan D, Donnelly S,Salkin ...
  • humanimmunodeficiency virus ...
  • infected patients in Israel ...
  • J ClinMicrobiol. ۲۰۰۰; ۳۸:۱۷۰ ...
  • PMID: ۱۰۶۱۸۰۸۲۲۳.Peltroche ...
  • Llacsahuanga H, Dohmen H, Haase G. Recovery ofCandida dubliniensisfrom sputum ...
  • ۲۰۰۲; ۴۵:۸ ...
  • PMID: ۱۱۸۵۶۴۳۱۲۴.AyatollahiMousavi SA, Khalesi E, ShahidiBonjar GH, AghighiS, Sharifi F, ...
  • RFLP. Biotechnology,۲۰۰۷; ۶: ۵۸۳ ...
  • Cirak YM, Kalkanci A, Kustimur S. Use of molecular methodsin ...
  • ۲۰۰۳; ۹۸:۱۰۲۷ ...
  • Pinto PM, Resende MA, Koga ...
  • Ito CY, Ferreira JA, Tendler M ...
  • RFLP identification ofCandidaspecies inimmunocompromised and seriously diseased patients. Can JMicrobiol ...
  • ۲۰۰۴; ۵۰:۵۰۴ ...
  • PMID: ۱۵۳۸۱۹۷۷۲۷. Shokohi T, Hashemi Soteh MB, Pouri ZS, Hedayati ...
  • RFLP incancer patients in Iran. Indian J Med Microbiol ...
  • ۲۰۱۰; ۲۸(۲): ۱۴۷ ...
  • PMID: ۲۰۴۰۴۴۶۲ ...
  • نمایش کامل مراجع